Compare Infosys Limited (INFY) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Infosys Limited vs State Street SPDR S&P Biotech ETF — how do they compare? Infosys Limited trades at $11.18 (market cap $46.65B), while State Street SPDR S&P Biotech ETF trades at $154.46. The key difference: Infosys Limited pays a 4.63% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Infosys Limited nearer its low. Which is the better fit depends on your goals.
| INFY | XBI | |
|---|---|---|
Market Cap | $46.65B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $20.22 | $164.28 |
52-Week Low | $10.49 | $85.16 |
Enterprise Value | $43.87B | — |
Dividend Yield | 4.63% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Infosys Limited
Infosys is a global leader in next-generation digital services and consulting. It enables clients in more than 50 countries to navigate their digital transformation through AI-powered cloud and data solutions.
Read more on INFY →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
